| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.0006 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |